According to a new report by Polaris Market Research, the U.S. DNA Manufacturing market was valued at USD 2.22 billion in 2024 and is projected to reach USD 11.72 billion by 2034, expanding at a CAGR of 18.14% over the forecast period. Growth is underpinned by the rising prevalence of rare diseases, expanding demand for personalized medicine, and increasing healthcare spending driving...
